Lupin Ltd.CMP -880
As you can see, the pharma stocks are presently in a short term uptrend
after a continuous decline since many years as well as having witnessed 6
months of market sluggishness in FH 2018. We are seeing good rise in pharma
stocks as a defensive play in the present market environment where only few
index stocks have risen and taken market to new highs. The IT and Pharma are
witnessing special short term trading momentum also due to the phenomenon in
forex markets where the Indian Rupee is seen at its new lows agains the USD.
Pharma, just like the IT firms are getting majority share of their revenue and
profit from overseas
So with support from the above logics and some frontline pharma stocks
almost making 52-week highs, Lupin is also above its 200 DMA in a way first
time since 2 years. We believe it will touch 1000 and then might go ahead. You are looking at an hourly chart where it has formed a bullish inverse head and shoulder pattern, while the RSI, MACD picture is also favourable as well.
It can be traded by taking position in Call option as well.
The given views are subject to change depending
on changing market and global economic conditions. Become member to benefit
from market and individual stock moves. Become member to get alerts for buy and sell with targets.
For
best services for traders and investors in Indian stock market for multibagger
stock calls and intraday stock, nifty, stock futures, options trading calls
visit our website www.meghacapital.in
